SCHEMBL6441891

SCHEMBL6441891

O=C(O)Cc1ccc(Oc2ccc(Cl)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.62
LTA4H P09960 1/20 0.57
EPHX2 P34913 1/20 0.57
NR3C1 P04150 1/20 0.54
S1PR5 Q9H228 1/20 0.54
THRA P10827 1/20 0.53
THRB P10828 1/20 0.53
PPARG P37231 3/20 0.53
PPARA Q07869 3/20 0.53
PTGDR2 Q9Y5Y4 2/20 0.51
CA2 P00918 1/20 0.50
CAMK2A Q9UQM7 1/20 0.50
DAGLA Q9Y4D2 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
FFAR1 O14842 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21243832 0.90 SRD5A2 (0.72) SRD5A2NR3C1THRATHRBCA2
SCHEMBL2999416 0.90 SRD5A2 (0.72) SRD5A2NR3C1THRATHRBCA2
SCHEMBL75665 0.88 CA2 (0.62) CA2CAMK2AFFAR1
Methane SCHEMBL1994900 0.86 CA2 (0.60) CA2CAMK2AFFAR1
Hydrochloric Acid SCHEMBL76051 0.86 CA2 (0.60) CA2CAMK2AFFAR1
SCHEMBL28038880 0.86 CA2 (0.60) CA2CAMK2AFFAR1
SCHEMBL11598621 0.85 NR4A2 (0.54) SRD5A2PPARGPPARACA2CAMK2A
SCHEMBL7628204 0.85 LTA4H (0.54) SRD5A2LTA4HEPHX2S1PR5PPARG
SCHEMBL1145770 0.84 SRD5A2 (0.83) SRD5A2LTA4HNR3C1FFAR1
SCHEMBL11596852 0.84 PLA2G4B (0.56) PPARGPTGDR2SMN1; SMN2FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1226128-B1 NEW PYRIMIDINE-2,4,6-TRIONE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS HOFFMANN LA ROCHE (CH) 2005-02-23 EP disclosed
US-6716845-B2 Barbituric acid derivatives HOFFMANN-LA ROCHE INC. 2004-04-06 US disclosed
EP-1383746-A2 NEW PYRIMIDINE-2,4,6-TRIONE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2004-01-28 EP disclosed
US-6498252-B1 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds HOFFMANN-LA ROCHE INC. 2002-12-24 US disclosed
US-20020187991-A1 Barbituric acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 2002-12-12 US disclosed
WO-2002079170-A2 PYRIMIDINE-2,4,6-TRIONE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THEM F. HOFFMANN-LA ROCHE AG (CH) 2002-10-10 WO disclosed
EP-1226128-A1 NEW PYRIMIDINE-2,4,6-TRIONE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-31 EP disclosed
WO-2001025217-A1 NEW PYRIMIDINE-2,4,6-TRIONE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-12 WO disclosed
EP-0556381-B1 N-(4-PYRIDYL OR 4-QUINOLINYL) ARYLACETAMIDE PESTICIDES DOW AGROSCIENCES LLC (US) 1999-04-28 EP disclosed
US-5597836-A NEMATOCIDES, INSECTICIDES, MITICIDES AND PLANT PATHOGENS DOWELANCO (US) 1997-01-28 US disclosed
EP-0556381-A4 DOWELANCO (US) 1995-06-21 EP disclosed
EP-0555469-A4 4-(ARALKOXY OR ARALKYLAMINO)PYRIDINE PESTICIDES----------------- DOWELANCO (US) 1995-06-21 EP disclosed
US-5399564-A N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides DOWELANCO (US) 1995-03-21 US disclosed
EP-0556381-A1 N-(4-PYRIDYL OR 4-QUINOLINYL) ARYLACETAMIDE PESTICIDES DOWELANCO (US) 1993-08-25 EP disclosed
EP-0555469-A1 4-(ARALKOXY OR ARALKYLAMINO)PYRIDINE PESTICIDES----------------- DOWELANCO (US) 1993-08-18 EP disclosed
WO-1993004580-A1 N-(4-PYRIDYL OR 4-QUINOLINYL) ARYLACETAMIDE PESTICIDES DOWELANCO (US) 1993-03-18 WO disclosed
WO-1993005050-A1 4-(ARALKOXY OR ARALKYLAMINO)PYRIDINE PESTICIDES_________________ DOWELANCO (US) 1993-03-18 WO disclosed
US-4168385-A LOWERING OF STEROL AND TRIGLYCERIDE SERUM LEVELS AMERICAN CYANAMID COMPANY (US) 1979-09-18 US disclosed
US-4125729-A Hypolipemic α-aryloxy para substituted phenyl acetic acid compounds AMERICAN CYANAMID COMPANY (US) 1978-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020187991-A1 Barbituric acid derivatives GABBR1, GABBR2, TUBB6 SRD5A2 529/4885LTA4H 2735/4885EPHX2 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.